These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 18633125
21. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis]. Li HB, Tie N, Jia YF, Shi L, Su Y, Zhang GZ, Wang Y, Bai LJ, Zhao J, Wang J, Xiao Z. Zhonghua Yi Xue Za Zhi; 2012 Jun 19; 92(23):1607-11. PubMed ID: 22944128 [Abstract] [Full Text] [Related]
22. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. El-Gabalawy HS, Robinson DB, Hart D, Elias B, Markland J, Peschken CA, Smolik I, Montes-Aldana G, Schroeder M, Fritzler MJ, Cheang M, Oen K. J Rheumatol; 2009 Jun 19; 36(6):1130-5. PubMed ID: 19411392 [Abstract] [Full Text] [Related]
23. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J, Frisch M. Arthritis Rheum; 2007 May 19; 56(5):1446-53. PubMed ID: 17469102 [Abstract] [Full Text] [Related]
24. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Johansson M, Arlestig L, Hallmans G, Rantapää-Dahlqvist S. Arthritis Res Ther; 2006 May 19; 8(1):R19. PubMed ID: 16507117 [Abstract] [Full Text] [Related]
25. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, Breedveld FC, Toes RE, Huizinga TW. Ann Rheum Dis; 2006 Mar 19; 65(3):366-71. PubMed ID: 16014670 [Abstract] [Full Text] [Related]
26. Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies. Cantaert T, Coucke P, De Rycke L, Veys EM, De Keyser F, Baeten D. Ann Rheum Dis; 2005 Sep 19; 64(9):1316-20. PubMed ID: 15760928 [Abstract] [Full Text] [Related]
27. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC. Arthritis Rheum; 2006 Jan 19; 54(1):90-6. PubMed ID: 16385500 [Abstract] [Full Text] [Related]
28. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles. Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, Jol-van der Zijde CM, van Tol MJ, Drijfhout JW, Breedveld FC, de Vries RR, Huizinga TW, Toes RE. Arthritis Rheum; 2007 Sep 19; 56(9):2913-8. PubMed ID: 17763436 [Abstract] [Full Text] [Related]
29. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies. Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G. Arthritis Rheum; 2009 Mar 19; 60(3):698-707. PubMed ID: 19248090 [Abstract] [Full Text] [Related]
30. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ. J Rheumatol; 2008 Jan 19; 35(1):77-83. PubMed ID: 18085741 [Abstract] [Full Text] [Related]
31. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH. Arthritis Rheum; 2009 Aug 19; 60(8):2232-41. PubMed ID: 19644872 [Abstract] [Full Text] [Related]
33. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population. Guzmán-Guzmán IP, Reyes-Castillo Z, Muñoz-Barrios S, Ruiz-Noa Y, Martínez-Bonilla GE, Parra-Rojas I, Palafox-Sánchez CA, Muñoz-Valle JF. Immunol Lett; 2015 Feb 19; 163(2):214-20. PubMed ID: 25562673 [Abstract] [Full Text] [Related]
34. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield A, Thomson W, Hajeer AH, Ollier WE. Arthritis Rheum; 2002 Aug 19; 47(4):403-7. PubMed ID: 12209487 [Abstract] [Full Text] [Related]
39. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Goëb V, Dieudé P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, Boumier P, Tron F, Gilbert D, Fardellone P, Cornélis F, Le Loët X, Vittecoq O. Rheumatology (Oxford); 2008 Aug 19; 47(8):1208-12. PubMed ID: 18535030 [Abstract] [Full Text] [Related]
40. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J. Arthritis Rheum; 2005 Nov 19; 52(11):3424-32. PubMed ID: 16255019 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]